Daewon Pharmaceutical Statistics

Total Valuation

KRX:003220 has a market cap or net worth of KRW 268.78 billion. The enterprise value is 421.66 billion.

Market Cap	268.78B
Enterprise Value	421.66B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

KRX:003220 has 21.43 million shares outstanding. The number of shares has decreased by -1.15% in one year.

Current Share Class	21.43M
Shares Outstanding	21.43M
Shares Change (YoY)	-1.15%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	38.80%
Owned by Institutions (%)	11.73%
Float	12.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	76.70
PS Ratio	0.46
PB Ratio	1.02
P/TBV Ratio	1.35
P/FCF Ratio	15.49
P/OCF Ratio	6.27
PEG Ratio	1.96

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.09, with an EV/FCF ratio of 24.30.

EV / Earnings	-26.29
EV / Sales	0.71
EV / EBITDA	18.09
EV / EBIT	n/a
EV / FCF	24.30

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.81.

Current Ratio	1.12
Quick Ratio	0.64
Debt / Equity	0.81
Debt / EBITDA	9.67
Debt / FCF	12.30
Interest Coverage	-0.05

Financial Efficiency

Return on equity (ROE) is -6.76% and return on invested capital (ROIC) is -0.05%.

Return on Equity (ROE)	-6.76%
Return on Assets (ROA)	-0.04%
Return on Invested Capital (ROIC)	-0.05%
Return on Capital Employed (ROCE)	-0.09%
Revenue Per Employee	460.40M
Profits Per Employee	-12.50M
Employee Count	1,283
Asset Turnover	0.98
Inventory Turnover	2.97

Taxes

In the past 12 months, KRX:003220 has paid 8.73 billion in taxes.

Income Tax	8.73B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.43% in the last 52 weeks. The beta is 0.21, so KRX:003220's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	-12.43%
50-Day Moving Average	12,969.80
200-Day Moving Average	13,388.45
Relative Strength Index (RSI)	42.87
Average Volume (20 Days)	43,074

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:003220 had revenue of KRW 590.70 billion and -16.04 billion in losses. Loss per share was -748.28.

Revenue	590.70B
Gross Profit	265.71B
Operating Income	-351.12M
Pretax Income	-9.97B
Net Income	-16.04B
EBITDA	22.07B
EBIT	-351.12M
Loss Per Share	-748.28

Full Income Statement

Balance Sheet

The company has 68.22 billion in cash and 213.42 billion in debt, giving a net cash position of -145.20 billion or -6,774.53 per share.

Cash & Cash Equivalents	68.22B
Total Debt	213.42B
Net Cash	-145.20B
Net Cash Per Share	-6,774.53
Equity (Book Value)	263.87B
Book Value Per Share	11,945.50
Working Capital	26.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 42.85 billion and capital expenditures -25.50 billion, giving a free cash flow of 17.35 billion.

Operating Cash Flow	42.85B
Capital Expenditures	-25.50B
Free Cash Flow	17.35B
FCF Per Share	809.55

Full Cash Flow Statement

Margins

Gross margin is 44.98%, with operating and profit margins of -0.06% and -2.71%.

Gross Margin	44.98%
Operating Margin	-0.06%
Pretax Margin	-1.69%
Profit Margin	-2.71%
EBITDA Margin	3.74%
EBIT Margin	-0.06%
FCF Margin	2.94%

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.39%.

Dividend Per Share	300.00
Dividend Yield	2.39%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.15%
Shareholder Yield	3.55%
Earnings Yield	-5.97%
FCF Yield	6.46%

Dividend Details

Stock Splits

The last stock split was on March 7, 2022. It was a forward split with a ratio of 1.03.

Last Split Date	Mar 7, 2022
Split Type	Forward
Split Ratio	1.03

Scores

KRX:003220 has an Altman Z-Score of 2.1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.1
Piotroski F-Score	2